Non-cystic Fibrosis Bronchiectasis Drug Pipeline Market 2024 Featuring Zambon, AstraZeneca, Insmed, NovaBiotics, Haisco Pharmaceutical, Armata Pharmaceuticals, Chiesi Farmaceutici, & CSL Behring
June 14, 2024 06:00 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Non-cystic...